TELOTRISTAT ETHYL for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where TELOTRISTAT ETHYL was used for Off label use.
Most Reported Side Effects for TELOTRISTAT ETHYL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 798 | 14.3% | 17 | 126 |
| Nausea | 610 | 10.9% | 8 | 97 |
| Constipation | 592 | 10.6% | 12 | 68 |
| Abdominal pain | 514 | 9.2% | 13 | 72 |
| Off label use | 495 | 8.8% | 22 | 64 |
| Fatigue | 395 | 7.1% | 10 | 60 |
| Flatulence | 390 | 7.0% | 7 | 30 |
| Flushing | 344 | 6.2% | 8 | 47 |
| Headache | 320 | 5.7% | 1 | 22 |
| Drug ineffective | 317 | 5.7% | 4 | 16 |
| Death | 315 | 5.6% | 315 | 50 |
| Malaise | 249 | 4.5% | 13 | 44 |
| Hospitalisation | 235 | 4.2% | 20 | 235 |
| Decreased appetite | 230 | 4.1% | 14 | 52 |
| Vomiting | 195 | 3.5% | 3 | 61 |
Other Indications for TELOTRISTAT ETHYL
Carcinoid syndrome (2,954)
Carcinoid tumour (1,281)
Neuroendocrine tumour (557)
Carcinoid tumour of the small bowel (488)
Product used for unknown indication (132)
Diarrhoea (76)
Carcinoid tumour of the gastrointestinal tract (52)
Carcinoid tumour of the duodenum (45)
Small intestine carcinoma (37)
Pancreatic carcinoma (33)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)